Violent behavior is of substantial social concern. Among potential biologic factors, serotonin (5-HT) neurotransmission has been widely implicated in aggressive behavior. A rich literature suggests that serotonergic (5-HT) activity is inversely associated with aggressive behavior in both human and non-human subjects. The human evidence for this relationship, however, consists almost exclusively of non-experimental research. Therefore, a causal relationship between serotonergic status and aggression in humans has not yet been clearly demonstrated. Theorists have proposed that serotonin influences aggressive behavior by altering the threshold at which an organism responds to provocative stimuli. According to this perspective, raising 5-HT levels should decrease aggressive responding to perceived provocation. At this time, however, no human experimental evidence for the interactive effects of provocation and 5-HT activity on aggression exists.
The first aim of this study is to demonstrate a causal relationship between serotonin activity and aggressive behavior in humans.
This aim will be addressed by determining if aggressive behavior is reduced after experimentally increasing brain levels of 5-HT. Specifically, 132 subjects (66 individuals with a history of impulsive aggression and 66 normal controls) will be randomly assigned to receive either an inactive placebo capsule or 0,5 mg/kg or 1.0 mg/kg d- fenfluramine (d-FEN). D-FEN has been shown to reliably increase indices of 5-HT functioning, decrease hostile ideation in humans, and some experimental evidence exists for the antiaggressive effects of this drug in animals. Approximately four hours after drug administration, aggressive responding will be observed using a laboratory paradign that has substantial empirical evidence supporting its validity.
The second aim of the study is to determine if provocation moderates the relationship between serotonin and aggression. Therefore, provocation by an adversary during an aggressive encounter will be manipulated as a within-subjects factor. It is hypothesized that aggressive behavior will be attenuated by d-FEN compared with placebo, especially under conditions of high-provocation. This effect is expected to be greater in individuals with a history of impulsive aggressive behavior compared with normal controls.
| Fanning, Jennifer R; Berman, Mitchell E; Guillot, Casey R et al. (2014) Serotonin (5-HT) augmentation reduces provoked aggression associated with primary psychopathy traits. J Pers Disord 28:449-61 |
| Dean, Andy C; Altstein, Lily L; Berman, Mitchell E et al. (2013) Secondary Psychopathy, but not Primary Psychopathy, is Associated with Risky Decision-Making in Noninstitutionalized Young Adults. Pers Individ Dif 54:272-277 |
| Berman, Mitchell E; McCloskey, Michael S; Fanning, Jennifer R et al. (2009) Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 20:714-20 |
| Berman, Mitchell E; Bradley, Tiffany P; Fanning, Jennifer R et al. (2009) Self-focused attention reduces self-injurious behavior in alcohol-intoxicated men. Subst Use Misuse 44:1280-97 |
| McCloskey, Michael S; Berman, Mitchell E; Echevarria, David J et al. (2009) Effects of acute alcohol intoxication and paroxetine on aggression in men. Alcohol Clin Exp Res 33:581-90 |
| East, Allison J; Berman, Mitchell E; Stoppelbein, Laura (2007) Familial association of anxiety sensitivity and psychopathology. Depress Anxiety 24:264-7 |
| Broman-Fulks, Joshua J; McCloskey, Michael S; Berman, Mitchell E (2007) Anxiety sensitivity and retaliatory aggressive behavior in research volunteers. Aggress Behav 33:137-44 |
| Berman, Mitchell E; Jones, Gabriele D; McCloskey, Michael S (2005) The effects of diazepam on human self-aggressive behavior. Psychopharmacology (Berl) 178:100-6 |
| McCloskey, Michael S; Berman, Mitchell E (2003) Alcohol intoxication and self-aggressive behavior. J Abnorm Psychol 112:306-11 |
| Weisman, A M; Berman, M E; Taylor, S P (1998) Effects of clorazepate, diazepam, and oxazepam on a laboratory measurement of aggression in men. Int Clin Psychopharmacol 13:183-8 |
Showing the most recent 10 out of 12 publications
